Market Cap

$6.9B

Volume

545.6K

Cash and Equivalents

$458.1M

EBITDA

-$51.6M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

$520.5M

Profit Margin

93.10%

52 Week High

$219.57

52 Week Low

$87.07

Dividend

N/A

Price / Book Value

9.38

Price / Earnings

-98.44

Price / Tangible Book Value

9.54

Enterprise Value

N/A

Enterprise Value / EBITDA

N/A

Operating Income

-$65.6M

Return on Equity

9.62%

Return on Assets

-4.58

Cash and Short Term Investments

$458.1M

Debt

$42.5M

Equity

$736.4M

Revenue

$559.0M

Unlevered FCF

-$23.7M

Sector

Pharmaceuticals

Category

N/A